Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

α4β2 nicotinic receptors play a role in the nAChR-mediated decline in l-dopa-induced dyskinesias in parkinsonian rats
Maryka Quik, Carla Cristian Campos, Tanuja Bordia, et al.
Neuropharmacology (2013) Vol. 71, pp. 191-203
Open Access | Times Cited: 44

Showing 1-25 of 44 citing articles:

Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease
Matthieu F. Bastide, Wassilios G. Meissner, Barbara Picconi, et al.
Progress in Neurobiology (2015) Vol. 132, pp. 96-168
Open Access | Times Cited: 430
Striatal synaptic adaptations in Parkinson's disease
Weixing Shen, Shenyu Zhai, D. James Surmeier
Neurobiology of Disease (2022) Vol. 167, pp. 105686-105686
Open Access | Times Cited: 46
Striatal cholinergic interneurons and Parkinson's disease
Asami Tanimura, Tristano Pancani, Sean Austin O. Lim, et al.
European Journal of Neuroscience (2017) Vol. 47, Iss. 10, pp. 1148-1158
Open Access | Times Cited: 82
Optogenetic activation of striatal cholinergic interneurons regulates L-dopa-induced dyskinesias
Tanuja Bordia, Xiomara A. Perez, Jaime E. Heiss, et al.
Neurobiology of Disease (2016) Vol. 91, pp. 47-58
Open Access | Times Cited: 74
Nicotine and Nicotinic Receptor Drugs
Maryka Quik, Tanuja Bordia, Danhui Zhang, et al.
International review of neurobiology (2015), pp. 247-271
Closed Access | Times Cited: 63
Striatal D1 medium spiny neuron activation induces dyskinesias in parkinsonian mice
Xiomara A. Perez, Danhui Zhang, Tanuja Bordia, et al.
Movement Disorders (2017) Vol. 32, Iss. 4, pp. 538-548
Open Access | Times Cited: 58
Role for the nicotinic cholinergic system in movement disorders; therapeutic implications
Maryka Quik, Danhui Zhang, Xiomara A. Perez, et al.
Pharmacology & Therapeutics (2014) Vol. 144, Iss. 1, pp. 50-59
Open Access | Times Cited: 56
Multiple CNS nicotinic receptors mediate l-dopa-induced dyskinesias: Studies with parkinsonian nicotinic receptor knockout mice
Maryka Quik, Carla Cristian Campos, Sharon R. Grady
Biochemical Pharmacology (2013) Vol. 86, Iss. 8, pp. 1153-1162
Open Access | Times Cited: 47
Nicotinic Receptor Agonists Reduce l-DOPA–Induced Dyskinesias in a Monkey Model of Parkinson's Disease
Danhui Zhang, Archana Mallela, David Sohn, et al.
Journal of Pharmacology and Experimental Therapeutics (2013) Vol. 347, Iss. 1, pp. 225-234
Open Access | Times Cited: 47
Mechanisms of Inhibition and Potentiation of α4β2 Nicotinic Acetylcholine Receptors by Members of the Ly6 Protein Family
Mei‐Lin Wu, Clare A. Puddifoot, Palmer Taylor, et al.
Journal of Biological Chemistry (2015) Vol. 290, Iss. 40, pp. 24509-24518
Open Access | Times Cited: 44
ABT‐089 and ABT‐894 reduce levodopa‐induced dyskinesias in a monkey model of Parkinson's disease
Danhui Zhang, Tanuja Bordia, Matthew McGregor, et al.
Movement Disorders (2014) Vol. 29, Iss. 4, pp. 508-517
Open Access | Times Cited: 43
AQW051, a novel and selective nicotinic acetylcholine receptor α7 partial agonist, reduces l-Dopa-induced dyskinesias and extends the duration of l-Dopa effects in parkinsonian monkeys
Thérèse Di Paolo, Laurent Grégoire, Dominik Feuerbach, et al.
Parkinsonism & Related Disorders (2014) Vol. 20, Iss. 11, pp. 1119-1123
Closed Access | Times Cited: 42
Neuroplasticity in levodopa-induced dyskinesias: An overview on pathophysiology and therapeutic targets
Francesco Bove, Benedetta Angeloni, Pasquale Sanginario, et al.
Progress in Neurobiology (2023) Vol. 232, pp. 102548-102548
Closed Access | Times Cited: 11
The Role of α7-Nicotinic Acetylcholine Receptors in the Pathophysiology and Treatment of Parkinson’s Disease
Eslam El Nebrisi, Yosra Lozon, Murat Öz
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 7, pp. 3210-3210
Open Access
Levodopa treatment: impacts and mechanisms throughout Parkinson’s disease progression
Peter Riederer, Sabrina Strobel, Toshiharu Nagatsu, et al.
Journal of Neural Transmission (2025)
Open Access
TC-8831, a nicotinic acetylcholine receptor agonist, reduces l-DOPA-induced dyskinesia in the MPTP macaque
Tom H. Johnston, Philippe Huot, Susan H. Fox, et al.
Neuropharmacology (2013) Vol. 73, pp. 337-347
Closed Access | Times Cited: 39
A new outlook on cholinergic interneurons in Parkinson’s disease and L-DOPA-induced dyskinesia
Melissa M. Conti, Nicole Chambers, Christopher Bishop
Neuroscience & Biobehavioral Reviews (2018) Vol. 92, pp. 67-82
Closed Access | Times Cited: 34
The α7 Nicotinic Receptor Agonist ABT-107 Decreases l-Dopa–Induced Dyskinesias in Parkinsonian Monkeys
Danhui Zhang, Matthew McGregor, Michael Decker, et al.
Journal of Pharmacology and Experimental Therapeutics (2014) Vol. 351, Iss. 1, pp. 25-32
Open Access | Times Cited: 33
Potential Therapeutic Application for Nicotinic Receptor Drugs in Movement Disorders
Maryka Quik, James T. Boyd, Tanuja Bordia, et al.
Nicotine & Tobacco Research (2018) Vol. 21, Iss. 3, pp. 357-369
Open Access | Times Cited: 32
Receptor Ligands as Helping Hands to L-DOPA in the Treatment of Parkinson’s Disease
Fabio Del Bello, Mario Giannella, Gianfabio Giorgioni, et al.
Biomolecules (2019) Vol. 9, Iss. 4, pp. 142-142
Open Access | Times Cited: 29
Attenuation of Compulsive-Like Behavior Through Positive Allosteric Modulation of α4β2 Nicotinic Acetylcholine Receptors in Non-Induced Compulsive-Like Mice
Swarup Mitra, McKenzie Mucha, Shailesh Khatri, et al.
Frontiers in Behavioral Neuroscience (2017) Vol. 10
Open Access | Times Cited: 28
α7 nicotinic receptor agonists reduce levodopa‐induced dyskinesias with severe nigrostriatal damage
Danhui Zhang, Matthew McGregor, Tanuja Bordia, et al.
Movement Disorders (2015) Vol. 30, Iss. 14, pp. 1901-1911
Open Access | Times Cited: 25
Preclinical Evidence for a Role of the Nicotinic Cholinergic System in Parkinson’s Disease
Xiomara A. Perez
Neuropsychology Review (2015) Vol. 25, Iss. 4, pp. 371-383
Closed Access | Times Cited: 23
Cholinergic control of striatal neurons to modulate L‐dopa‐induced dyskinesias
Tanuja Bordia, Xiomara A. Perez
European Journal of Neuroscience (2018) Vol. 49, Iss. 6, pp. 859-868
Closed Access | Times Cited: 23
α7-Nicotinic acetylcholine receptor antagonist QND7 suppresses non-small cell lung cancer cell proliferation and migration via inhibition of Akt/mTOR signaling
Wasita Witayateeraporn, Kuntarat Arunrungvichian, Sutthaorn Pothongsrisit, et al.
Biochemical and Biophysical Research Communications (2019) Vol. 521, Iss. 4, pp. 977-983
Closed Access | Times Cited: 19
Page 1 - Next Page

Scroll to top